Abstract:The aim of the study was to investigate the risk factors of preprocedural laboratory investigations and drug effects to the incidence of contrast-induced nephropathy (CIN) in patients with diabetes who underwent coronary angiography or percutaneous coronary intervention and to assess the short-term safety. We retrospectively studied a total of 568 patients with diabetes who underwent coronary angiography or percutaneous coronary intervention from January, 2013 to January, 2014 in our hospital and compared the baseline clinical characteristics, especially the laboratory investigations and preprocedural drugs of those 2 groups (with CIN group and without CIN group), and half year follow-up. Overall, 53 (9.33%) patients were developed into CIN according to the definition of an increase of 25% from the baseline of serum creatinine concentration, supposing that on the basis of an increase of 44.2 μmol/L, the incidence would be 0.88% (5/568). No significant differences were found between the 2 groups with respect to age, diabetes mellitus duration, operation type, contrast type and volume, left ventricular ejection fraction, and combined diseases including hypertension, myocardial infarction, Arrhythmia, etc. However, patients with CIN tended to be lighter in body weight (P = 0.027) and were more often female [odds ratio (OR) = 2.8, P < 0.01], and also had a higher prevalence with acute coronary syndrome (OR = 5.1, P < 0.01). On the contrary to most studies, the preprocedural serum creatinine in with CIN group in our study was lower than without CIN group (P < 0.001). As for the preprocedural drugs, statins seemed could decrease the incidence of CIN (OR = 0.34, P < 0.05), and the use of diuretics might increase the occurrence of CIN (OR = 2.62, P < 0.05). As regard to the follow-up results, the hospitalization days and expense of with CIN group were significantly longer and higher than the without CIN group, but no significance was found between rehospitalization rate in half year. Preprocedural preventions are essential because there is no effective treatment for CIN our findings could be considered in clinical practice. There are many risk factors for CIN; it is necessary to distinguish the high-risk patients so as to carry out corresponding protection actions.

Perirenal Fat Thickness Is Associated With Contrast‐Induced Nephropathy in Type 2 Diabetic Patients Undergoing Coronary Catheterization

Perirenal Fat Thickness Is Significantly Associated With the Risk for Development of Chronic Kidney Disease in Patients With Diabetes

Perirenal fat thickness is associated with metabolic risk factors in patients with chronic kidney disease

Perirenal Fat Thickness Contributes to the Estimated 10-Year Risk of Cardiovascular Disease and Atherosclerotic Cardiovascular Disease in Type 2 Diabetes Mellitus

Increased Urinary Adiponectin Level is Associated with Contrast-Induced Nephropathy in Patients Undergoing Elective Percutaneous Coronary Intervention

The Utility of Perirenal Fat in Determining the Risk of Onset and Progression of Diabetic Kidney Disease

Perirenal fat and chronic kidney disease in type 2 diabetes: The mediation role of afferent arteriolar resistance

The association between nutritional risk and contrast-induced acute kidney injury in patients undergoing coronary angiography: a cross-sectional study

Drug Effects and Clinical Investigations for Contrast-Induced Nephropathy after Coronary Angiography or Percutaneous Coronary Intervention in Patients with Diabetes.

The effect of different glucose metabolism and related factors on the contrast-induced nephropathy

Related factors of contrast-induced nephropathy after percutaneous coronary intervention in patients with coronary artery disease and diabetes mellitus

Para-perirenal fat thickness is associated with reduced glomerular filtration rate regardless of other obesity-related indicators in patients with type 2 diabetes mellitus

Association between fasting stress hyperglycemia ratio and contrast-induced acute kidney injury in coronary angiography patients: a cross-sectional study

Obesity as a Risk Factor for Radiographic Contrast-Induced Nephropathy

Pericardial fat is associated with coronary artery calcification in non-dialysis dependent chronic kidney disease patients

Predictors of contrast nephropathy after percutaneous intervention of chronic total occlusion in patients with chronic coronary syndrome: A single-center study

INCREASED URINARY ADIPONECTIN LEVEL IS ASSOCIATED WITH CONTRAST-INDUCED NEPHROPATHY IN PATIENTS UNDERGOING PCI

Preoperative Fasting Blood Glucose Levels and the Risk of Contrast-Induced Nephropathy in Patients with Diabetes and Pre-diabetes Undergoing Coronary Arteriography or Percutaneous Coronary Intervention: A Cross-Sectional Study

Evaluating the Differential Risk of Contrast-Induced Nephropathy Among Diabetic and Non-diabetic Patients Following Percutaneous Coronary Intervention

Perirenal Fat Thickness: A Surrogate Marker for Metabolic Syndrome in Chinese Newly Diagnosed Type 2 Diabetes

Role of Serum Cystatin C in the Prediction of Contrast-Induced Nephropathy after Intra-Arterial Interventions